Illicit drug markets differ in two key ways: monopolies and duopolies dominate and they suffer from asymmetric information problems, with buyers lacking information about the quality or content of products [41].This disguised sale complicates our ability to determine whether users like these drugs or not, but also suggests that those supplying them